The Accretion Nutraveda IPO is a BSE SME book-building public issue. The IPO opened for subscription on January 27, 2026 and closed on January 30, 2026. The issue is a fresh issue with a total size of ₹24.77 crore.
🔍 Accretion Nutraveda IPO Allotment Status
The Accretion Nutraveda IPO allotment is expected to be finalized on Monday, February 2, 2026. After the allotment is completed, investors can check their allotment status online using their PAN, application number, or DP ID through the official registrar portal.
Status: ALLOTMENT PENDING / UPCOMING
Refund initiation and credit of shares to demat accounts are scheduled for February 3, 2026. The equity shares of Accretion Nutraveda Ltd. are expected to list on the BSE SME platform on February 4, 2026.
📌 Accretion Nutraveda IPO Details
- Issue Size: ₹24.77 crore
- Price Band: ₹122 – ₹129 per share
- Lot Size: 1,000 shares
- Minimum Retail Investment: ₹2,58,000
- Face Value: ₹10 per share
- Issue Type: Book-Building IPO (Fresh Issue)
- Listing: BSE SME
- Registrar: KFin Technologies Ltd.
📅 IPO Timeline
| IPO Open Date | Jan 27, 2026 |
| IPO Close Date | Jan 30, 2026 |
| Allotment Date | Feb 2, 2026 |
| Refunds / Demat Credit | Feb 3, 2026 |
| Listing Date | Feb 4, 2026 |
🏢 About Accretion Nutraveda Ltd.
Accretion Nutraveda Limited, incorporated in 2021, is engaged in the manufacturing of Ayurvedic and nutraceutical products across multiple dosage forms including tablets, capsules, oral liquids, powders, oils, balms, creams, and gels.
The company operates as a Contract Development and Manufacturing Organization (CDMO), catering to both domestic and international markets such as Sri Lanka, Singapore, and the United States. Its business model includes domestic sales, merchant exports, and direct exports.
Accretion Nutraveda focuses on quality-driven manufacturing, automation, and scalable production facilities. The IPO proceeds will be used for machinery installation, capacity expansion, working capital requirements, and general corporate purposes.
Bookmark this page to stay updated on the Accretion Nutraveda IPO allotment status, refund updates, and BSE SME listing performance.